Taking position: Effect of SGLT2i on arterial pressure, vascular damage, kidney disease and associated cardiovascular risk

被引：0

作者：

Inserra, Felipe ^{[1
,2
,3
,4
]}

Forte, Ezequiel ^{[5
]}

Elbert, Alicia ^{[6
]}

Waisman, Gabriel ^{[1
]}

Castellaro, Carlos ^{[3
]}

Buso, Carlos ^{[5
]}

Fairman, Enrique ^{[5
]}

Cobo, Augusto Lavalle ^{[5
]}

Manucha, Walter ^{[5
]}

Salmeri, Emiliano ^{[5
]}

Sanabria, Hugo ^{[5
]}

Sanchez, Ramiro ^{[5
]}

Terns, Paula Perez ^{[5
]}

Aranguren, Florencia ^{[6
]}

Arias, Pablo ^{[6
]}

Castano, Yanina ^{[6
]}

De Marziani, Guillermo ^{[6
]}

Faingold, Cristina ^{[6
]}

Gonzalez, Joaquin ^{[6
]}

Jawerbaum, Alicia ^{[6
]}

Vazquez, Fabiana ^{[6
]}

Wappner, Diego ^{[6
]}

Zaidel, Ezequiel J. ^{[6
]}

Aiello, Ernesto A. ^{[1
]}

Alfie, Jose ^{[1
]}

De Cerchio, Alejandro ^{[1
]}

Choi, Marcelo ^{[1
]}

Marquez, Diego ^{[1
]}

Piskorz, Daniel ^{[1
]}

Pupi, Luis Maria ^{[1
]}

Renna, Nicolas ^{[1
]}

Salazar, Martin ^{[1
]}

Dorado, Enrique ^{[3
]}

Ferder, Leon ^{[3
]}

Lavenia, Gustavo ^{[3
]}

Orias, Marcelo ^{[3
]}

Paganti, Luciana Gonzalez ^{[3
]}

Rigo, Diego H. ^{[3
]}

Diez, Guillermo Rosa ^{[3
]}

Sivak, Leonardo ^{[3
]}

Trimarchi, Hernan ^{[3
]}

Majul, Claudio ^{[5
]}

Sinay, Isaac ^{[5
]}

Marin, Marcos ^{[5
]}

Bonanno, Carlos ^{[5
]}

机构：

[1] Soc Argentina Hipertens Arterial, Buenos Aires, Argentina

[2] Com Salud Renal & Hipertens Arterial & Dano Vasc, Buenos Aires, Argentina

[3] Soc Argentina Nefrol, Buenos Aires, Argentina

[4] Univ Austral, Mecan Vasc Hipertens Arterial, Buenos Aires, Argentina

[5] Soc Argentina Cardiol, Buenos Aires, Argentina

[6] Soc Argentina Diabet, Buenos Aires, Argentina

来源：

REVISTA DE NEFROLOGIA DIALISIS Y TRASPLANTE | 2024年 / 44卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：49 / 51

页数：3

共 50 条

[1] Diabetes Mellitus, Arterial Stiffness and Cardiovascular Disease: Clinical Implications and the Influence of SGLT2i
Lamacchia, Olga
Sorrentino, Maria Rosaria
CURRENT VASCULAR PHARMACOLOGY, 2021, 19 (02) : 233 - 240
[2] SGLT2i: new perspectives in diabetes and kidney disease
Ferrannini, Giulia
Cosentino, Francesco
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (03) : E4 - E4
[3] Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction Call for Action to the Cardiology Community
Nelson, Adam J.
Pagidipati, Neha J.
Aroda, Vanita R.
Cavender, Matthew A.
Green, Jennifer B.
Lopes, Renato D.
Al-Khalidi, Hussein
Gaynor, Tanya
Kaltenbach, Lisa A.
Kirk, Julienne K.
Lingvay, Ildiko
Magwire, Melissa L.
O'Brien, Emily C.
Pak, Jonathan
Pop-Busui, Rodica
Richardson, Caroline R.
Reed, Monica
Senyucel, Cagri
Webb, Laura
McGuire, Darren K.
Granger, Christopher B.
CIRCULATION, 2021, 144 (01) : 74 - 84
[4] Uptake and Predictors of SGLT2i in Patients with Type 2 Diabetes and Cardiovascular Disease
Ozaki, Aya F.
Ko, Dennis T.
Chong, Alice
Fang, Jiming
Austin, Peter
Stukel, Therese
Booth, Gillian
Tu, Karen
Udell, Jacob A.
Atzema, Clare
Naimark, David
Jackevicius, Cynthia A.
CIRCULATION, 2021, 144
[5] Impact of Baseline Clinical Variables on SGLT2i's Antiproteinuric Effect in Diabetic Kidney Disease
Capelli, Irene
Ribichini, Danilo
Provenzano, Michele
Vetrano, Daniele
Aiello, Valeria
Cianciolo, Giuseppe
Vicennati, Valentina
Tomassetti, Alessandro
Moschione, Ginevra
Berti, Sabrina
Pagotto, Uberto
La Manna, Gaetano
LIFE-BASEL, 2023, 13 (04):
[6] ADDITIVE CARDIOVASCULAR RISK REDUCTION OF GLP1A AND SGLT2I IN DIABETIC PATIENTS WITH ATHEROSCLEROTIC DISEASE
Loyo, Persio Lopez
Bohra, Chandrashekar
Bhatia, Kirtipal
Baruch, Lawrence
Eng, Calvin
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1430 - 1430
[7] The role of SGLT2i in attenuating residual cardiovascular risk through blood pressure-lowering: mechanistic insights and perspectives
Barreto, Joaquim
Campos-Staffico, Alessandra M.
Nadruz, Wilson
Quinaglia, Thiago
Sposito, Andrei C.
FRONTIERS IN CLINICAL DIABETES AND HEALTHCARE, 2023, 4
[8] Response to the Nephrological perspectives on the underutilization of SGLT2i in heart failure and chronic kidney disease
Kocabas, Umut
ESC HEART FAILURE, 2025,
[9] Response to the Nephrological perspectives on the underutilization of SGLT2i in heart failure and chronic kidney disease
Kocabas, Umut
ESC HEART FAILURE, 2025, 12 (02): : 1492 - 1493
[10] Risk of CKD among patients with DM taking diuretics or SGLT2i: a retrospective cohort study in Taiwan
Lin, Han-Jie
Shih, Pin-Yang
Tsai, Stella Chin-Shaw
Chuang, Wu-Lung
Hsieh, Tsai-Ling
Lin, Heng-Jun
Yu, Teng-Shun
Tsai, Fuu-Jen
Chen, Chiu-Ying
Chang, Kuang-Hsi
BMC PHARMACOLOGY & TOXICOLOGY, 2024, 25 (01):

← 1 2 3 4 5 →